Since Peli1 exerts its oncogenic role by K63 ubiquitination of Bcl-6, an important driver molecule of DLBCL 6, we hypothesized that Peli1 may have a distinct clinical significance according to Bcl-6 status on the basis of molecular oncogenic mechanism. Here, PELI1 is linked to diffuse large B-cell lymphoma.